Senzime contracts new CFO
Press release: Uppsala, June 18, 2019. Senzime AB (publ) today announces that the company hascontracted Erik Bergman as new CFO and member of the management team. Erik succeeds Jessica Roxhed as CFO and takes office on October 1, 2019.Erik Berman, B Sc in Business Administration and Economics, with more than 30 years of experience from senior positions in small and medium-sized listed or private companies within Life Science. Erik comes from a position as CEO of the vaccine adjuvant company Novavax AB, and since autumn 2018 he has worked at Senzime to a lesser extent via his own company.